Overview

Topotecan Weekly Versus Topotecan Day 1-5 in Patient With Platin-resistant Ovarian Cancer

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
Comparison of topotecan weekly vs. topotecan day 1-5. The compatibility and activity are to be examined.
Phase:
Phase 2
Details
Lead Sponsor:
North Eastern German Society of Gynaecological Oncology
North Eastern Germany Society of Gynaecologic Oncology
Treatments:
Topotecan